Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Stanford Cancer Center South Bay · San Jose, California
Answer a few short questions to share with the research team.